Literature DB >> 31813098

Feasibility and safety of same day subcutaneous defibrillator implantation and send home (DASH) strategy.

Toshimasa Okabe1, Adrianne Miller2, Tanner Koppert2, Rafael Cavalcanti2, Diego Alcivar-Franco2, Jemina Osei2, Omar Kahaly2, Muhammad R Afzal2, Jaret Tyler2, Steven J Kalbfleisch2, Raul Weiss2, Mahmoud Houmsse2, Ralph S Augostini2, Emile G Daoud2, Michael J Andritsos3, Sujatha Bhandary4, Galina Dimitrova4, Kasey Fiorini4, Hamdy Elsayed-Awad4, Antolin Flores4, Leonid Gorelik4, Manoj H Iyer4, Samiya Saklayen4, Erica Stein4, Katja Turner4, William Perez4, John D Hummel2, Michael K Essandoh4.   

Abstract

PURPOSE: To assess the feasibility and safety of same-day discharge after S-ICD implantation by implementing a specific analgesia protocol and phone follow-up.
METHODS: Consecutive patients presenting for outpatient S-ICD implantation were enrolled between 1/1/2018 and 4/30/2019. An analgesia protocol included pre-operative acetaminophen and oxycodone, intraoperative local bupivacaine, and limited use of oxycodone-acetaminophen at discharge. The primary outcome was successful same-day discharge. Numerical Pain Rating Scale (NPRS) on postoperative day (POD) 1, 3, 14, and 30 and any unplanned health care visits during the 1-month follow-up period were assessed.
RESULTS: Out of 53 potentially eligible S-ICD patients, 49 patients (92.5%) were enrolled and successfully discharged on the same day. Mean age of these 49 patients was 47 ± 14 years. There were no acute procedural complications. Severe pain (NPRS ≥ 8) on POD 0, 1, and 3 was present in 14.3%, 14.3%, and 8.2% of patients, respectively. The total in-hospital stay was 534 ± 80 min. Four unplanned visits (8%) due to cardiac or device-related issues occurred during 1-month follow-up, including 2 patients with heart failure exacerbation, one patient with an incisional infection, and one patient with inappropriate shocks.
CONCLUSIONS: With the appropriate institutional protocol including specific analgesics and phone follow-up, same-day discharge after outpatient S-ICD implantation is feasible and appears safe for most patients.. Device-related pain can be severe in the first 3 days post-implantation and can be successfully treated with limited supply of narcotic medications.

Entities:  

Keywords:  Analgesics; Outpatient; Pain control; Same-day discharge; Subcutaneous defibrillator

Mesh:

Year:  2019        PMID: 31813098     DOI: 10.1007/s10840-019-00673-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  The role of anesthesia in surgical mortality.

Authors:  R D DRIPPS; A LAMONT; J E ECKENHOFF
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

2.  Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Authors:  Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

3.  Bupivacaine liposomal versus bupivacaine: comparative review.

Authors:  John Noviasky; Deirdre P Pierce; Karen Whalen; Roy Guharoy; Kenneth Hildreth
Journal:  Hosp Pharm       Date:  2014-06

4.  Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.

Authors:  Michael R Gold; Johan D Aasbo; Mikhael F El-Chami; Mark Niebauer; John Herre; Jordan M Prutkin; Bradley P Knight; Steven Kutalek; Kevin Hsu; Raul Weiss; Eric Bass; Michael Husby; Timothy M Stivland; Martin C Burke
Journal:  Heart Rhythm       Date:  2017-05-11       Impact factor: 6.343

5.  Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.

Authors:  Daniel J Friedman; Craig S Parzynski; Paul D Varosy; Jordan M Prutkin; Kristen K Patton; Ali Mithani; Andrea M Russo; Jeptha P Curtis; Sana M Al-Khatib
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

6.  A postanesthetic recovery score.

Authors:  J A Aldrete; D Kroulik
Journal:  Anesth Analg       Date:  1970 Nov-Dec       Impact factor: 5.108

7.  Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.

Authors:  Pietro Francia; Matteo Ziacchi; Paolo De Filippo; Stefano Viani; Antonio D'Onofrio; Vincenzo Russo; Carmen Adduci; Mauro Biffi; Paola Ferrari; Valter Bianchi; Ernesto Ammendola; Francesca Palano; Jessica Frisoni; Sergio Valsecchi; Mariolina Lovecchio; Maria Grazia Bongiorni
Journal:  J Interv Card Electrophysiol       Date:  2018-03-03       Impact factor: 1.900

Review 8.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

9.  Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation.

Authors:  Andrea Droghetti; Erika Basso Ricci; Paolo Scimia; Fabiola Harizai; Massimiliano Marini
Journal:  Pacing Clin Electrophysiol       Date:  2018-04-15       Impact factor: 1.976

10.  Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians.

Authors:  Michael K Essandoh; George E Mark; Johan D Aasbo; Charles A Joyner; Saumya Sharma; Beningo F Decena; Eric D Bolin; Raul Weiss; Martin C Burke; Timothy R McClernon; Emile G Daoud; Michael R Gold
Journal:  Pacing Clin Electrophysiol       Date:  2018-06-08       Impact factor: 1.976

View more
  1 in total

1.  A real-world experience of subcutaneous and transvenous implantable cardiac defibrillators-comparison with the PRAETORIAN study.

Authors:  Dibbendhu Khanra; Abdul Hamid; Peysh Patel; John Tomson; Ahmed Abdalla; Nasrin Khan; Rory Dowd; Nakul Chandan; Christopher Osagie; Tomilola Jinadu; Selvakumar Velu; Anita Arya; Charles Spencer; Craig Barr; Sanjiv Petkar
Journal:  J Arrhythm       Date:  2022-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.